search
Back to results

Obesity Treatment Using an Internet-delivered Intervention Based on the Diabetes Prevention Program in Mexican Adults (DPPON-MEX)

Primary Purpose

Obesity or Overweight

Status
Completed
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
ID-DPP group
Wait-list Group
Sponsored by
Universidad de Sonora
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity or Overweight focused on measuring Obesity, Overweight, Lifestyle Intervention, Randomized controlled Trial, Internet delivered, Online, Weight loss

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Mexican adults (≥ 18 years and ≤60)
  • Residents of the city of Hermosillo, Sonora
  • Overweight or obese (BMI ≥ 25 and ≤45)
  • Internet access at home
  • Basic computer skills
  • Facebook active account
  • Candidates must make records of their food consumption for 5 days.

Exclusion Criteria:

  • Substance abuse
  • Consumption of more than 14 alcoholic beverages per week (equivalent to 280 g of alcohol)
  • Diagnosis of psychiatric conditions that could prevent adherence to treatment
  • Previous diagnosis of medical conditions with significant effect on body weight
  • Diagnosis of diabetes
  • Systolic blood pressure> 160 mm / Hg
  • Pregnant women who are breastfeeding or who plan to become pregnant during the study period
  • Consumption of medications with an effect on body weight such as metformin, orlistat or glucocorticoids.
  • Participating in another program to reduce weight or performing structured physical exercise other than walking> 180 min / week
  • Plan to participate in some treatment for weight loss during the study
  • Any other condition in which weight loss or physical activity is contraindicated
  • Previous diagnosis of kidney failure, cancer or any other condition that requires special treatment
  • Relatives participating in the study
  • Have plans to change residence
  • Criteria of the researcher - for clinical reasons or adherence to the protocol
  • Weight loss>5% of total body weight in the previous 4 months

Sites / Locations

  • Centro de Promoción de Salud Nutricional (CPSN)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

ID-DPP group

Wait-list Group

Arm Description

Internet-delivered intervention based on the DPP

Outcomes

Primary Outcome Measures

Change in body weight

Secondary Outcome Measures

Change in body weight
Change in body mass index
Change in waist circumference
Change in body fat percentage
Change in the Beck Depression Inventory Scale
The Beck Depression Inventory (BDI) is a 21-item questionnaire that assesses mood over the previous week. Total scores range from 0 to 63, with higher values indicating more severe symptoms of depression. Scores of 0-9 reflect minimal (subclinical) symptoms, values of 10-18, 19-29, and ≥30 indicate mild, moderate, and severe symptoms of depression, respectively.
Change in the Short Form-36 Health Survey Score
The SF-36 Health Survey evaluates aspects of quality of life in adult populations (over 16 years of age). The result of its application is the generation of eight concepts or scales of health, which is the result of the average of the sum of all questions contained in the questionnaire for each concept. These eight concepts are: physical function, physical role, corporal pain, general health, vitality, social function, emotional role and mental health. The SF-36 is a self-applied instrument and contains 36 questions. For each scale, the answer to each question is coded and recoded (10 questions), and the results are interpreted on a scale of 0 to 100, with lower scores indicating poorer health and higher scores better health.
Change in systolic and diastolic blood pressure
Change in fasting glucose
Change in total cholesterol
Change in LDL-cholesterol
Change in HDL-cholesterol
Change in triglycerides
Change in gamma glutamyl transferase
Number of participants achieving 5% of weight loss

Full Information

First Posted
August 10, 2018
Last Updated
April 27, 2021
Sponsor
Universidad de Sonora
search

1. Study Identification

Unique Protocol Identification Number
NCT03629301
Brief Title
Obesity Treatment Using an Internet-delivered Intervention Based on the Diabetes Prevention Program in Mexican Adults
Acronym
DPPON-MEX
Official Title
Efficacy of an Internet-delivered Intervention Based on the Diabetes Prevention Program for Weight Loss in Overweight and Obese Mexican Adults: 3 and 6 Months Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
September 17, 2018 (Actual)
Primary Completion Date
July 31, 2019 (Actual)
Study Completion Date
October 30, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad de Sonora

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In Mexico, 7 out of 10 adults are overweight or obese. The diseases associated with these conditions (diabetes, cardiovascular disease and some cancers) are those that impact the most on the disability-adjusted life years of Mexicans and on their mortality rates. A reduction in body weight of 5-10% can reduce the incidence of obesity related diseases. The gold standard for treating obesity is an intensive lifestyle change program such as the Diabetes Prevention Program (DPP) whose effectiveness has been evaluated in various formats and populations with positive results, including in Mexico. However, the DPP is not accessible to all sectors of the population. To increase its dissemination, the implementation of online interventions based on the DPP (oi-DPP) has been proposed. A systematic review of oi-DPP showed promising results, however, the evidence is limited and the lack of studies of high methodological quality is highlighted. The main objective of this project is to evaluate the efficacy of an oi-DPP for weight loss in Mexican adults with overweight or obesity at 3 months. The study design is a randomized controlled trial with 2 arms: oi-DPP and wait-list control. A 3 months pilot study (n=30) will be conducted prior to the main study to estimate sample size, considering an alpha error of 0.05 and power of 80%. The primary outcome is the mean change in body weight from baseline to 3 months post-baseline between the 2 groups. Secondarily, differences in biochemical parameters (fasting glucose, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides and gamma glutamyl transferase) from baseline to 3 months will be evaluated, as well as mean changes from baseline to 3 and 6 months in body mass index, waist circumference, systolic and diastolic blood pressure, depression and quality of life scales and the number of participants achieving a weight loss greater than 5% of initial body weight. Body weight will be also evaluated at 6 months post-baseline. The previous measurements will apply both in the pilot study and the study except for the biochemical parameters that will only be included in the main study. The differences between the 2 groups for each variable will be analyzed using a t test for independent samples, in case of having a parametric sample. Otherwise, the Mann-Whitney U test will be used. Analysis will follow the intent-to-treat principle.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity or Overweight
Keywords
Obesity, Overweight, Lifestyle Intervention, Randomized controlled Trial, Internet delivered, Online, Weight loss

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
62 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ID-DPP group
Arm Type
Experimental
Arm Description
Internet-delivered intervention based on the DPP
Arm Title
Wait-list Group
Arm Type
Other
Intervention Type
Behavioral
Intervention Name(s)
ID-DPP group
Intervention Description
This group will receive a 6 month long online behavioral change protocol adapted from the Diabetes Prevention Program. It includes 18 sessions, 12 delivered weekly (during the first 3 months) and 6 delivered biweekly (during the last 3 month period). A web page will be used to deliver the sessions, while the nutritional counseling will be delivered using video calls via Facebook chat. Participants will receive an hypocaloric (1200-1800 kcal, carbohydrates: 45-65%, fats: 20-35% and protein: 10-35%), personalized diet.
Intervention Type
Other
Intervention Name(s)
Wait-list Group
Intervention Description
This group will only receive written information with recommendations on healthy eating. When the study has finished this group will receive a behavioral change protocol with nutritional counseling using a face-to-face format.
Primary Outcome Measure Information:
Title
Change in body weight
Time Frame
baseline to 3 months
Secondary Outcome Measure Information:
Title
Change in body weight
Time Frame
baseline to 6 months
Title
Change in body mass index
Time Frame
baseline to 3 months and baseline to 6 months
Title
Change in waist circumference
Time Frame
baseline to 3 months and baseline to 6 months
Title
Change in body fat percentage
Time Frame
baseline to 3 months and baseline to 6 months
Title
Change in the Beck Depression Inventory Scale
Description
The Beck Depression Inventory (BDI) is a 21-item questionnaire that assesses mood over the previous week. Total scores range from 0 to 63, with higher values indicating more severe symptoms of depression. Scores of 0-9 reflect minimal (subclinical) symptoms, values of 10-18, 19-29, and ≥30 indicate mild, moderate, and severe symptoms of depression, respectively.
Time Frame
baseline to 3 months and baseline to 6 months
Title
Change in the Short Form-36 Health Survey Score
Description
The SF-36 Health Survey evaluates aspects of quality of life in adult populations (over 16 years of age). The result of its application is the generation of eight concepts or scales of health, which is the result of the average of the sum of all questions contained in the questionnaire for each concept. These eight concepts are: physical function, physical role, corporal pain, general health, vitality, social function, emotional role and mental health. The SF-36 is a self-applied instrument and contains 36 questions. For each scale, the answer to each question is coded and recoded (10 questions), and the results are interpreted on a scale of 0 to 100, with lower scores indicating poorer health and higher scores better health.
Time Frame
baseline to 3 months and baseline to 6 months
Title
Change in systolic and diastolic blood pressure
Time Frame
baseline to 3 months and baseline to 6 months
Title
Change in fasting glucose
Time Frame
baseline to 3 months
Title
Change in total cholesterol
Time Frame
baseline to 3 months
Title
Change in LDL-cholesterol
Time Frame
baseline to 3 months
Title
Change in HDL-cholesterol
Time Frame
baseline to 3 months
Title
Change in triglycerides
Time Frame
baseline to 3 months
Title
Change in gamma glutamyl transferase
Time Frame
baseline to 3 months
Title
Number of participants achieving 5% of weight loss
Time Frame
baseline to 3 months and baseline to 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Mexican adults (≥ 18 years and ≤60) Residents of the city of Hermosillo, Sonora Overweight or obese (BMI ≥ 25 and ≤45) Internet access at home Basic computer skills Facebook active account Candidates must make records of their food consumption for 5 days. Exclusion Criteria: Substance abuse Consumption of more than 14 alcoholic beverages per week (equivalent to 280 g of alcohol) Diagnosis of psychiatric conditions that could prevent adherence to treatment Previous diagnosis of medical conditions with significant effect on body weight Diagnosis of diabetes Systolic blood pressure> 160 mm / Hg Pregnant women who are breastfeeding or who plan to become pregnant during the study period Consumption of medications with an effect on body weight such as metformin, orlistat or glucocorticoids. Participating in another program to reduce weight or performing structured physical exercise other than walking> 180 min / week Plan to participate in some treatment for weight loss during the study Any other condition in which weight loss or physical activity is contraindicated Previous diagnosis of kidney failure, cancer or any other condition that requires special treatment Relatives participating in the study Have plans to change residence Criteria of the researcher - for clinical reasons or adherence to the protocol Weight loss>5% of total body weight in the previous 4 months
Facility Information:
Facility Name
Centro de Promoción de Salud Nutricional (CPSN)
City
Hermosillo
State/Province
Sonora
ZIP/Postal Code
83000
Country
Mexico

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Obesity Treatment Using an Internet-delivered Intervention Based on the Diabetes Prevention Program in Mexican Adults

We'll reach out to this number within 24 hrs